APM
Avidity Partners Management Portfolio holdings
AUM
$499M
1-Year Return
3.47%
This Quarter Return
+7.12%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.58B
AUM Growth
+$609M
(+20%)
Cap. Flow
+$540M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
34.78%
Holding
131
New
36
Increased
33
Reduced
15
Closed
37
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$103M |
| 2 |
Medtronic
MDT
|
$85.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$80.2M |
| 4 |
Nuvation Bio
NUVB
|
$78.6M |
| 5 |
AbbVie
ABBV
|
$78M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$137M |
| 2 |
Quest Diagnostics
DGX
|
$94.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$87.1M |
| 4 |
Organogenesis Holdings
ORGO
|
$73.9M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$57.5M |
Sector Composition
| 1 | Healthcare | 96.26% |
| 2 | Financials | 0.29% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immunocore
IMCR
$1.78B
| $23.4M | 0.65% |
+550,000
| New | +$23.4M |
|
52
Curis
CRIS
$21.4M
| $23.2M | 0.64% |
102,689
-14,416
| -12% | -$3.26M |
|
53
Aurinia Pharmaceuticals
AUPH
$1.65B
| $23.2M | 0.64% |
1,784,000
-216,000
| -11% | -$2.8M |
|
54
Cardiff Oncology
CRDF
$142M
| $22.7M | 0.63% |
2,447,700
+840,700
| +52% | +$7.78M |
|
|
IGMS
55
DELISTED
IGM Biosciences
IGMS
| $22.5M | 0.62% |
293,000
+213,000
| +266% | +$16.3M |
|
56
Bolt Biotherapeutics
BOLT
$9.29M
| $21.5M | 0.59% |
+32,715
| New | +$21.5M |
|
|
CMRX
57
DELISTED
Chimerix, Inc.
CMRX
| $21.5M | 0.59% |
+2,230,000
| New | +$21.5M |
|
|
GRTS
58
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $20M | 0.55% |
2,122,064
| – | – |
|
59
Bioventus
BVS
$475M
| $19.2M | 0.53% |
+1,254,333
| New | +$19.2M |
|
|
SGTX
60
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $19M | 0.53% |
65,459
+12,536
| +24% | +$3.64M |
|
61
SI-BONE Inc
SIBN
$705M
| $18.4M | 0.51% |
577,570
-62,314
| -10% | -$1.98M |
|
62
Collegium Pharmaceutical
COLL
$1.24B
| $17.5M | 0.48% |
740,000
-499,000
| -40% | -$11.8M |
|
|
ONCS
63
DELISTED
OncoSec Medical Incorporated
ONCS
| $16.6M | 0.46% |
157,727
+69,000
| +78% | +$7.24M |
|
|
ALPN
64
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $16M | 0.44% |
1,511,000
+263,000
| +21% | +$2.79M |
|
|
PHAS
65
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $14.8M | 0.41% |
+4,285,000
| New | +$14.8M |
|
66
Kezar Life Sciences
KZR
$28M
| $11.4M | 0.31% |
+190,708
| New | +$11.4M |
|
67
Pharvaris
PHVS
$1.41B
| $11.2M | 0.31% |
+400,000
| New | +$11.2M |
|
|
ADMS
68
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $10.6M | 0.29% |
+2,200,200
| New | +$10.6M |
|
|
AFMD
69
DELISTED
Affimed
AFMD
| $10.3M | 0.28% |
+129,600
| New | +$10.3M |
|
70
Merus
MRUS
$5.01B
| $10.2M | 0.28% |
+487,000
| New | +$10.2M |
|
71
SCYNEXIS
SCYX
$36.4M
| $10M | 0.28% |
1,263,769
+8,769
| +0.7% | +$69.6K |
|
72
Instil Bio
TIL
$205M
| $10M | 0.28% |
+20,000
| New | +$10M |
|
73
Immatics
IMTX
$695M
| $9.92M | 0.27% |
+884,600
| New | +$9.92M |
|
74
Terns Pharmaceuticals
TERN
$618M
| $8.8M | 0.24% |
+400,000
| New | +$8.8M |
|
|
EVLO
75
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $8.56M | 0.24% |
+40,000
| New | +$8.56M |
|